Open AccessSAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR+DASABUVIR IN CHRONIC HEPATITIS C PATIENTS WITH HCV GENOTYPE 1 INFECTION
Author(s) -
Tomasz Tatara,
Marta Dąbrowska-Bender,
Anna Staniszewska,
Aneta Duda-Zalewska
Publication year - 2019
Publication title -
acta poloniae pharmaceutica - drug research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.17
H-Index - 42
eISSN - 2353-5288
pISSN - 0001-6837
DOI - 10.32383/appdr/105681
Subject(s) - dasabuvir , ombitasvir , ritonavir , paritaprevir , virology , medicine , hepatitis c , chronic hepatitis , genotype , human immunodeficiency virus (hiv) , ribavirin , biology , viral load , virus , biochemistry , antiretroviral therapy , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom